IGM Biosciences Inc reports results for the quarter ended in December - Earnings Summary

IGM Biosciences

30/03/2023 22:01

* IGM Biosciences Inc  IGMS.OQ  reported a quarterly
adjusted loss
of $1.19​​ per share for the quarter ended in December. The mean
expectation of eleven analysts for the quarter was for a loss of
$1.25 per share.
    * Revenue was $372.00 thousand​; analysts expected $301.25
thousand. 
    * IGM Biosciences Inc's reported EPS for the quarter was a
loss of
$1.19​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * IGM Biosciences Inc shares had risen by 1.5% this quarter.
    * The company reported a quarterly loss of $52.58 million.
    * Wall Street's median 12-month price target for IGM
Biosciences
Inc is $38.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 30 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.25          -1.19          Beat
 Sep. 30 2022      -1.43          -1.32          Beat
 Jun. 30 2022      -0.94          -1.33          Missed
 Mar. 31 2022      -1.61          -1.53          Beat